This opportunity funds clinical observational research projects focused on musculoskeletal, rheumatic, and skin diseases. Clinical trials are not allowed. The funding uses the R01 mechanism with a simplified review process to support rigorous observational studies conducted by eligible U.S. organizations.
Eligible applicants include a wide range of U.S. organizations such as federally recognized Native American tribal governments, nonprofits, public and private institutions of higher education, government entities, and small businesses. Specific eligibility details are provided in the full announceme
